Issue 63, 2019

Structure–activity–distribution relationship study of anti-cancer antimycin-type depsipeptides

Abstract

Small-molecule natural products have been an essential source of pharmaceuticals to treat human diseases, but very little is known about their behavior inside dynamic, live human cells. Here, we demonstrate the first structure–activity–distribution relationship (SADR) study of complex natural products, the anti-cancer antimycin-type depsipeptides, using the emerging bioorthogonal Stimulated Raman Scattering (SRS) Microscopy. Our results show that the intracellular enrichment and distribution of these compounds are driven by their potency and specific protein targets, as well as the lipophilic nature of compounds.

Graphical abstract: Structure–activity–distribution relationship study of anti-cancer antimycin-type depsipeptides

Supplementary files

Article information

Article type
Communication
Submitted
19 Apr 2019
Accepted
11 Jul 2019
First published
16 Jul 2019

Chem. Commun., 2019,55, 9379-9382

Author version available

Structure–activity–distribution relationship study of anti-cancer antimycin-type depsipeptides

J. Seidel, Y. Miao, W. Porterfield, W. Cai, X. Zhu, S. Kim, F. Hu, S. Bhattarai-Kline, W. Min and W. Zhang, Chem. Commun., 2019, 55, 9379 DOI: 10.1039/C9CC03051D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements